Shanghai Huaota Biopharmaceutical Co., Ltd.

This study tests a new drug called HB0025 combined with chemotherapy against the standard treatment (pembrolizumab plus chemo) for people with advanced or spreading squamous non-small cell lung cancer who haven't had treatment before. About 480 adults will take part, receiving ei…

This study tests a new drug called HB0025 combined with chemotherapy against the current standard treatment (tislelizumab plus chemo) for people with advanced nonsquamous non-small cell lung cancer that cannot be removed by surgery. About 500 adults aged 18 to 75 will receive eit…

This early-stage trial tests a new drug called HB0043 in 21 adults with moderate to severe facial acne. The drug targets two proteins linked to acne inflammation. The main goal is to see if it is safe and reduces acne lesions and severity scores compared to a placebo.